FLETCHER R JOHN 4

What Happened

• Fletcher R. John, a director of ClearPoint Neuro, had 12,417 restricted stock units (RSUs) settle into 12,417 shares on May 19, 2026. The Form 4 records an "exercise/conversion of derivative (M)" acquiring 12,417 shares and a simultaneous disposition of 12,417 shares. No per‑share price or total dollar value is reported in the filing.

Key Details

• Transaction date: May 19, 2026; Form 4 filed May 21, 2026 (appears timely).
• Grant date / vesting terms: RSUs were granted May 22, 2025 and vested on the earlier of the first anniversary or the day before the 2026 annual meeting (per footnote).
• Shares acquired: 12,417 (via RSU settlement). Simultaneous disposition: 12,417 (reason not specified in filing).
• Price / value: Not disclosed (listed as N/A).
• Shares owned after transaction: Not specified on the filing.
• Footnote: Confirms each RSU converts to one share and this transaction represents scheduled RSU settlement.

Context

• This was an RSU settlement (an award converting to shares), not an open‑market buy or sell. The filing also shows a matching disposition of the same shares; the Form 4 does not state the reason (e.g., tax withholding or transfer). RSU settlements are routine compensation events and do not, by themselves, indicate insider sentiment. For further detail, consult the full Form 4 and the company’s disclosures.